Literature DB >> 20446793

Glomerular lesion and increased cytokine gene expression in renal tissue in patients with decompensated nephrotic syndrome due to chronic GvHD.

D Kaminska1, B Bernat, O Vakulenko, J Kuzniar, B Tyran, K Suchnicki, A Lange, O Mazanowska, A Halon, M Klinger.   

Abstract

The nephrotic syndrome is a rare complication of allogeneic stem cell transplantation (alloHSCT). We present two cases of nephrotic syndrome during chronic graft-versus-host disease (GvHD) involving altered cytokine gene expression in renal tissue. A patient with acute lymphatic leukemia demonstrated nephrotic syndrome due to minimal change disease as a marker of chronic GvHD. A patient with acute lymphoblastic leukemia suffered from severe nephrotic syndrome due to membranous glomerulopathy. In the two presented cases of GvHD-linked nephrotic syndrome, increased cytokine gene expression [tumor necrosis factor alpha (TNF-alpha), transforming growth factor beta (TGF-beta), interferon gamma (IFN-gamma), interleukin 2 (IL-2), IL-6, and IL-10] assessed using semiquantitative evaluation with reverse transcriptase polymerase chain reaction (RT-PCR) in situ on renal biopsy was observed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20446793     DOI: 10.3109/08860221003664256

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  4 in total

1.  Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation.

Authors:  Gregory A Yanik; Shin Mineishi; John E Levine; Carrie L Kitko; Eric S White; Mark T Vander Lugt; Andrew C Harris; Thomas Braun; Kenneth R Cooke
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-10       Impact factor: 5.742

2.  Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity.

Authors:  L Grkovic; K Baird; S M Steinberg; K M Williams; D Pulanic; E W Cowen; S A Mitchell; F T Hakim; K J Martires; D N Avila; T N Taylor; R B Salit; S D Rowley; D Zhang; D H Fowler; M R Bishop; R E Gress; S Z Pavletic
Journal:  Leukemia       Date:  2011-10-18       Impact factor: 11.528

3.  Minimal change disease in graft versus host disease: a podocyte response to the graft?

Authors:  Janna Huskey; Chris Rivard; Han Myint; Scott Lucia; Maxwell Smith; Michiko Shimada; Takuji Ishimoto; Carlos Araya; Eduardo H Garin; Richard J Johnson
Journal:  Clin Nephrol       Date:  2013-12       Impact factor: 0.975

4.  Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters.

Authors:  Tamara Vukić; Sean Robinson Smith; Dina Ljubas Kelečić; Lana Desnica; Ema Prenc; Dražen Pulanić; Radovan Vrhovac; Damir Nemet; Steven Z Pavletic
Journal:  Croat Med J       Date:  2016-06-30       Impact factor: 1.351

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.